Treatment of malignant melanoma with methyl CCNU

Clin Pharmacol Ther. 1974 Jun;15(6):617-22. doi: 10.1002/cpt1974156617.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Body Surface Area
  • Clinical Trials as Topic
  • Cyclohexanes / administration & dosage
  • Cyclohexanes / adverse effects
  • Cyclohexanes / therapeutic use
  • Female
  • Hematopoiesis / drug effects
  • Humans
  • Kidney / drug effects
  • Leukocyte Count
  • Liver / drug effects
  • Male
  • Melanoma / drug therapy*
  • Middle Aged
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local
  • Nitrosourea Compounds / administration & dosage
  • Nitrosourea Compounds / adverse effects
  • Nitrosourea Compounds / therapeutic use*
  • Thrombocytopenia / chemically induced
  • Time Factors

Substances

  • Antineoplastic Agents
  • Cyclohexanes
  • Nitrosourea Compounds